Metformin increases pathologic complete response rates in breast...

Courtesy EurekAlert! - Cancer  Sun, 06/01/2008 - 23:00

(University of Texas M. D. Anderson Cancer Center) Metformin, the common first-line drug for type 2 diabetes, may be effective in increasing pathologic complete response rates in diabetic women with early stage breast cancer who took the drug during chemotherapy prior to having surgery, paving the way for further research of the drug as a potential cancer therapy, according to researchers at the University of Texas M.

D. Anderson Cancer Center.

Sponsors
Tags:

 

Related items

M. D. Anderson study finds racial disparities in radiation...
(University of Texas M. D. Anderson Cancer Center) Black women are less likely than white women to receive radiation therapy after a lumpectomy, the...

Mammography may be beneficial to all women, regardless of age
According to researchers at The University of Texas M. D. Anderson Cancer Center, mammography, the gold-standard for breast cancer screening and...

Creating lung cancer risk models for specific populations...
(University of Texas M. D. Anderson Cancer Center) Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by...

M. D. Anderson study finds change in HER2 status after...
(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when...

Faulty DNA repair could be a risk factor for lung cancer in...
(American Association for Cancer Research) People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com